Publications by authors named "Olga Millán"

39Publications

Early prognostic performance of miR155-5p monitoring for the risk of rejection: Logistic regression with a population pharmacokinetic approach in adult kidney transplant patients.

PLoS One 2021 22;16(1):e0245880. Epub 2021 Jan 22.

Pharmacology and Toxicology Laboratory, Biochemistry and Molecular Genetics, Biomedical Diagnostic Center (CDB), Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.

View Article and Find Full Text PDF
January 2021

MicroRNAs 155-5p, 122-5p, and 181a-5p Identify Patients With Graft Dysfunction Due to T Cell-Mediated Rejection After Liver Transplantation.

Liver Transpl 2020 10 2;26(10):1275-1286. Epub 2020 Sep 2.

Liver Transplant Unit, Hospital Clínic Barcelona, Institut d'Investigacions Biomèdiques August Pi I Sunyer, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, University of Barcelona, Barcelona, Spain.

View Article and Find Full Text PDF
October 2020

Nuclear factor of activated T cells as potential pharmacodynamic biomarker for the risk of acute and subclinical rejection in de novo liver recipients.

Liver Int 2020 04 22;40(4):931-946. Epub 2020 Jan 22.

Biomedical Research Centre in Hepatic and Digestive Diseases (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain.

View Article and Find Full Text PDF
April 2020

Pharmacodynamic Monitoring of mTOR Inhibitors.

Ther Drug Monit 2019 04;41(2):160-167

Pharmacology and Toxicology Laboratory, Biomedical Diagnostic Center (CDB), CIBERehd, IDIBAPS, Hospital Clínic of Barcelona, University of Barcelona, Barcelona, Spain.

View Article and Find Full Text PDF
April 2019

Urinary miR-155-5p and CXCL10 as prognostic and predictive biomarkers of rejection, graft outcome and treatment response in kidney transplantation.

Br J Clin Pharmacol 2017 12 21;83(12):2636-2650. Epub 2017 Sep 21.

Pharmacology and Toxicology Laboratory, CDB, IDIBAPS, Hospital Clinic of Barcelona, University of Barcelona, Spain.

View Article and Find Full Text PDF
December 2017

Pharmacodynamics of T cell function for monitoring pharmacologic immunosuppression after allogeneic hematopoietic stem cell transplantation.

Int J Hematol 2017 Apr 23;105(4):497-505. Epub 2016 Nov 23.

Pharmacology and Toxicology Department, Biomedical Diagnostic Center, Hospital Clínic, University of Barcelona, Barcelona, Spain.

View Article and Find Full Text PDF
April 2017

High expression of CD38, CD69, CD95 and CD154 biomarkers in cultured peripheral T lymphocytes correlates with an increased risk of acute rejection in liver allograft recipients.

Immunobiology 2016 May 25;221(5):595-603. Epub 2016 Jan 25.

Immunology Service, Clinical University Hospital ́Virgen de la Arrixacá-IMIB (Murcian Institute of Biomedical Investigation), Murcia, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Spain. Electronic address:

View Article and Find Full Text PDF
May 2016

High proportion of pretransplantation activated regulatory T cells (CD4+CD25highCD62L+CD45RO+) predicts acute rejection in kidney transplantation: results of a multicenter study.

Transplantation 2014 Dec;98(11):1213-8

1 Servicio de Inmunología, Hospital Universitario Marqués de Valdecilla-IFIMAV, Santander, Spain. 2 Farmacología y Toxicología, Centro de Diagnóstico Biomédico, IDIBAPS, Hospital Clínico, Universidad de Barcelona, Barcelona, Spain. 3 Servicio de Epidemiología, Gerencia de Atención Primaria-IFIMAV, Santander, Spain. 4 Servicio de Inmunología, Hospital Universitario Virgen Arrixaca, Murcia, Spain. 5 Instituto de Investigación del Hospital 12 de Octubre, Servicio de Inmunología Hospital 12 de Octubre, Facultad de Medicina Universidad Complutense de Madrid, Universidad CEU San Pablo, Madrid, Spain. 6 Instituto de Investigación del Hospital 12 de Octubre, Servicio de Inmunología Hospital 12 de Octubre, Madrid, Spain. 7 Instituto de Investigación del Hospital 12 de Octubre, Servicio de Nefrología Hospital 12 de Octubre, Facultad de Medicina Universidad Complutense de Madrid, Madrid, Spain. 8 Farmacología Clínica, Hospital Universitario Marqués de Valdecilla-IFIMAV, Santander, Spain. 9 Unidad de Trasplante Renal, Servicio de Nefrologia, Fundació Puigvert, Barcelona, Spain. 10 Servicio de Nefrologia, Hospital Universitario Virgen Arrixaca, Murcia, Spain. 11 Servicio de Nefrología, Hospital del Mar, Barcelona, Spain. 12 Servicio de Nefrología, Hospital Universitario Marqués de Valdecilla-IFIMAV, Santander, Spain. 13 Address correspondence to: Marcos López-Hoyos, M.D., Ph.D., Servicio de Inmunología. Hospital Universitario Marqués de Valdecilla. Avenida Valdecilla s/n. CP 39008. Santander, Cantabria, Spain.

View Article and Find Full Text PDF
December 2014

Donor-recipient genetic diversity: the role of
pharmacogenomics in kidney transplantation.

Pharmacogenomics 2013 Sep;14(12):1369-72

Farmacología y Toxicología, Centro de Diagnóstico Biomédico, IDIBAPS, CIBERehd, Hospital Clínico, Universidad de Barcelona, Spain

View Article and Find Full Text PDF
September 2013